ADVANZ PHARMA Corp. Limited Sustainability Profile
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of specialty and generic medicines. Founded in 2018, the company has rapidly established itself across key operational regions, including Europe and North America, focusing on therapeutic areas such as oncology, neurology, and infectious diseases. With a commitment to providing high-quality, accessible healthcare solutions, ADVANZ PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a growing market presence, positioning itself as a trusted provider in the pharmaceutical landscape. Through innovation and a patient-centric approach, ADVANZ PHARMA continues to enhance its reputation and impact within the healthcare sector.
DitchCarbon Score
How does ADVANZ PHARMA Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ADVANZ PHARMA Corp. Limited's score of 28 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ADVANZ PHARMA Corp. Limited's reported carbon emissions
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, ADVANZ PHARMA's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies, but ADVANZ PHARMA has yet to publicly commit to such measures.
How Carbon Intensive is ADVANZ PHARMA Corp. Limited's Industry?
How Carbon Intensive is ADVANZ PHARMA Corp. Limited's Location?
ADVANZ PHARMA Corp. Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ADVANZ PHARMA Corp. Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
